Mina Hanna1, Patrick D Brophy2, Peter J Giannone1, Mandar S Joshi1, John A Bauer1, Satish RamachandraRao3,4. 1. Department of Pediatrics, University of Kentucky College of Medicine, Lexington, Kentucky. 2. Department of Pediatrics, University of Iowa, Iowa City, Iowa. 3. O'Brien Center for AKI Research, University of California-San Diego, San Diego, California. 4. Department of Cell Biology and Molecular Genetics, Devaraj Urs Medical College, Kolar, India.
Abstract
BACKGROUND: Acute kidney injury (AKI) in the neonatal intensive care setting is multifactorial and is associated with significant morbidity and mortality. This study evaluates the utility of novel urinary biomarkers to predict the development and/or severity AKI in preterm infants. METHODS: We performed a case-control study on a prospective cohort of preterm infants (<32 wk), to compare seven urine biomarkers between 25 infants with AKI and 20 infants without AKI. RESULTS: Infants with AKI had significantly higher neutrophil gelatinase-associated lipocalin (NGAL) (median, control (CTRL) vs. AKI; 0.598 vs. 4.24 µg/ml; P < 0.0001). In contrast, urinary epidermal growth factor (EGF) levels were significantly lower in infants who developed AKI compared to controls (median, CTRL vs. AKI; 0.016 vs. 0.006 µg/ml; P < 0.001). The area under the curve (AUC) for NGAL for prediction of stage I AKI on the day prior to AKI diagnosis (day-1) was 0.91, and for the prediction of stage II/III, AKI was 0.92. Similarly, urine EGF was a predictor of renal injury on day -1 (AUC: 0.97 for stage I and 0.86 for stage II/III AKI). CONCLUSION: Urinary biomarkers may be useful to predict AKI development prior to changes in serum creatinine (SCr) in preterm infants.
BACKGROUND:Acute kidney injury (AKI) in the neonatal intensive care setting is multifactorial and is associated with significant morbidity and mortality. This study evaluates the utility of novel urinary biomarkers to predict the development and/or severity AKI in preterm infants. METHODS: We performed a case-control study on a prospective cohort of preterm infants (<32 wk), to compare seven urine biomarkers between 25 infants with AKI and 20 infants without AKI. RESULTS:Infants with AKI had significantly higher neutrophil gelatinase-associated lipocalin (NGAL) (median, control (CTRL) vs. AKI; 0.598 vs. 4.24 µg/ml; P < 0.0001). In contrast, urinary epidermal growth factor (EGF) levels were significantly lower in infants who developed AKI compared to controls (median, CTRL vs. AKI; 0.016 vs. 0.006 µg/ml; P < 0.001). The area under the curve (AUC) for NGAL for prediction of stage I AKI on the day prior to AKI diagnosis (day-1) was 0.91, and for the prediction of stage II/III, AKI was 0.92. Similarly, urine EGF was a predictor of renal injury on day -1 (AUC: 0.97 for stage I and 0.86 for stage II/III AKI). CONCLUSION: Urinary biomarkers may be useful to predict AKI development prior to changes in serum creatinine (SCr) in preterm infants.
Authors: Maria M Rodríguez; Alexander H Gómez; Carolyn L Abitbol; Jayanthi J Chandar; Shahnaz Duara; Gastón E Zilleruelo Journal: Pediatr Dev Pathol Date: 2004 Jan-Feb
Authors: José David Herrero-Morín; Serafín Málaga; Nuria Fernández; Corsino Rey; María Angeles Diéguez; Gonzalo Solís; Andrés Concha; Alberto Medina Journal: Crit Care Date: 2007 Impact factor: 9.097
Authors: Antonella Barbati; Maria Cristina Aisa; Benito Cappuccini; Mariarosalba Zamarra; Sandro Gerli; Gian Carlo Di Renzo Journal: Pediatr Res Date: 2020-05-18 Impact factor: 3.756
Authors: David J Askenazi; Brian A Halloran; Patrick J Heagerty; Robert H Schmicker; Patrick Brophy; Sandra E Juul; Sangeeta Hingorani; Stuart L Goldstein Journal: Pediatr Res Date: 2021-11-30 Impact factor: 3.953
Authors: Simona Riccio; Maria Sole Valentino; Antonio Paride Passaro; Marica Izzo; Stefano Guarino; Emanuele Miraglia Del Giudice; Pierluigi Marzuillo; Anna Di Sessa Journal: Children (Basel) Date: 2022-01-17